HBV RNA in serum is an early predictor for sustained immune control following treatment with pegylated interferon alfa in patients with HBeAg negative chronic hepatitis B

Author
Hansen, B.
Tabak, F.
Feld, J.
Janssen, H.
Cakaloglu, Y.
Farag, M.
Campenhout, M. V.
van Boemmel, F.
Rijckborst, V.
Ferenci, P.
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/42933
https://doi.org/10.1016/s0168-8278(18)31269-8
Collections